SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-292621
Filing Date
2023-12-11
Accepted
2023-12-11 16:34:02
Documents
13
Period of Report
2023-12-05
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d833600d8k.htm   iXBRL 8-K 27125
2 EX-3.1 d833600dex31.htm EX-3.1 100427
  Complete submission text file 0001193125-23-292621.txt   277532

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cort-20231205.xsd EX-101.SCH 2851
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cort-20231205_lab.xml EX-101.LAB 17981
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cort-20231205_pre.xml EX-101.PRE 11259
7 EXTRACTED XBRL INSTANCE DOCUMENT d833600d8k_htm.xml XML 3529
Mailing Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025 650.688.8803
CORCEPT THERAPEUTICS INC (Filer) CIK: 0001088856 (see all company filings)

IRS No.: 770487658 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50679 | Film No.: 231478598
SIC: 2834 Pharmaceutical Preparations